Read Time:9 Second
Medtronic’s stock rose toward a three-month high Tuesday, after the medical-technology company topped fiscal first-quarter earnings expectations, amid strength in its diabetes and cardiovascular business.
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %
0
0
